Patents by Inventor Advait Vijay Badkar

Advait Vijay Badkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CORONAVIRUS VACCINE
    Publication number: 20240002127
    Abstract: The present disclosure relates to the fields of packaging, transportation, and storage of temperature-sensitive materials, such as biological and/or pharmaceutical products. Various aspects of such packaging, transportation, and storage are provided herein for ultra-low temperature materials useful for the treatment and/or prevention of disease. The present disclosure also provides packaging materials, methods of transportation, and methods of storage for maintaining biological and/or pharmaceutical materials at ultra-low temperatures in order to maintain the integrity of the materials. The present disclosure further relates to the field of RNA to prevent or treat coronavirus infection.
    Type: Application
    Filed: April 16, 2021
    Publication date: January 4, 2024
    Inventors: Marjoh Nauta, Dirk Jozef Peeters, Tom Frank Steven Van Doorslaer, Advait Vijay Badkar, Ramin Darvari, Nicholas William Warne, James Jean, Danny Pierre G. Hendrikse, Ugur Sahin, Alptekin Güler, Andreas Kuhn, Alexander Muik, Annette Vogel, Kerstin Walzer, Sonja Witzel, Stephanie Hein, Özlem Türeci
  • IMMUNOGENIC COMPOSITION AGAINST INFLUENZA
    Publication number: 20220362372
    Abstract: The invention relates to compositions and methods for the preparation, manufacture and therapeutic use ribonucleic acid vaccines comprising polynucleotide molecules encoding one or more influenza antigens, such as hemagglutinin antigens.
    Type: Application
    Filed: April 29, 2022
    Publication date: November 17, 2022
    Inventors: Philip Ralph Dormitzer, Advait Vijay Badkar, Christina Van Geen Hoven, Kathrin Ute Jansen, Pirada Suphaphiphat Allen, Ramin Darvari, Mark Duda
  • STABLE LIQUID ANTIBODY FORMULATION
    Publication number: 20220175663
    Abstract: The present invention relates generally to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by a liquid formulation of a humanised anti-NGF antibody.
    Type: Application
    Filed: July 16, 2021
    Publication date: June 9, 2022
    Inventors: Advait Vijay Badkar, Leigh Kristen Bohack, Kevin Roger King, Alanta Lea Lary
  • Stable Liquid Antibody Formulation
    Publication number: 20190314272
    Abstract: The present invention relates generally to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by a liquid formulation of a humanised anti-NGF antibody.
    Type: Application
    Filed: December 14, 2018
    Publication date: October 17, 2019
    Inventors: Advait Vijay Badkar, Leigh Kristen Bohack, Kevin Roger King, Atlanta Lea Lary
  • Stable liquid antibody formulation
    Patent number: 10188600
    Abstract: The present invention relates generally to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by a liquid formulation of a humanized anti-NGF antibody.
    Type: Grant
    Filed: September 18, 2009
    Date of Patent: January 29, 2019
    Assignee: Pfizer Inc.
    Inventors: Advait Vijay Badkar, Leigh Kristen Bohack, Kevin Roger King, Alanta Lea Lary
  • STABLE LIQUID ANTIBODY FORMULATION
    Publication number: 20110171217
    Abstract: The present invention relates generally to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by a liquid formulation of a humanised anti-NGF antibody.
    Type: Application
    Filed: September 18, 2009
    Publication date: July 14, 2011
    Inventors: Advait Vijay Badkar, Leigh Kristen Bohack, Kevin Roger King, Atanta Lea Lary